Bioscience firm planning major expansion in Silver Spring Posted on June 21, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Bioscience, Biotech • Leave a comment http://www.bizjournals.com/washington/breaking_ground/2015/06/bioscience-firm-planning-major-expansion-in-silver.html?ana=e_du_wknd&s=article_du&ed=2015-06-20&u=FAuoHGaGEPdmk4X6khnaiw045b16af&t=1434902705 Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Treatment results position this biotech to surpass the $6B threshold Posted on June 15, 2015 by henrykotula • Posted in Uncategorized • Tagged Biotech, Gene Therapy, Healthcare • Leave a comment http://www.bizjournals.com/boston/blog/bioflash/2015/06/treatment-results-position-this-biotech-to-surpass.html?ana=e_vert_st_20150615 Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Five (non-cancer) areas Bristol-Myers Squibb is pursuing hard Posted on June 9, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biotech, Healthcare, Research • Leave a comment Five (non-cancer) areas Bristol-Myers Squibb is pursuing hard Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Yale spinout Isoplexis raises $2.4M for “cellular fingerprinting” tech that analyzes immune response Posted on May 30, 2015 by henrykotula • Posted in Uncategorized • Tagged Biochip, Biotech, Cellular Fingerprinting, Healthcare, Personalized Medicine, Single Cell Immunoassay Device • Leave a comment Yale spinout Isoplexis raises $2.4M for “cellular fingerprinting” tech that analyzes immune response Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Soon-Shiong back to his roots: NantWorks acquires next-gen Abraxane in potential $1.3B deal Posted on May 16, 2015 by henrykotula • Posted in Uncategorized • Tagged Biopharmaceutical, Biotech, Cancer Treatment, Healthcare, Precision Cancer Medicine • Leave a comment Soon-Shiong back to his roots: NantWorks acquires next-gen Abraxane in potential $1.3B deal Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Medtech venture capital: Opportunistic vs. commitment styles of investment Posted on May 8, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biopharmaceutical, Biotech, Private Equity, Venture Capital • Leave a comment Medtech venture capital: Opportunistic vs. commitment styles of investment Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Flagship Ventures raises $537M in new fund; plans to launch 5 companies per year Posted on March 28, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biotech, Healthcare, Life Sciences, Med Device, Private Equity, Venture Capital • Leave a comment Flagship Ventures raises $537M in new fund; plans to launch 5 companies per year Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Johnson & Johnson opening another JLABS accelerator in South San Francisco Posted on March 7, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biotech, Healthcare • Leave a comment Johnson & Johnson opening another JLABS accelerator in South San Francisco Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Angel investing in healthcare continues to grow. But can it keep fitting in? Posted on February 22, 2015 by henrykotula • Posted in Uncategorized • Tagged Angel Investors, Biomed, Biotech, Crowdfunding, Healthcare, Private Equity, Venture Capital • Leave a comment Angel investing in healthcare continues to grow. But can it keep fitting in? Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Arcturus emerging as a strong player in RNA therapeutics space Posted on February 16, 2015 by henrykotula • Posted in Uncategorized • Tagged Biomed, Biotech, Healthcare, Therapeutics • Leave a comment Arcturus emerging as a strong player in RNA therapeutics space Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
HENRY KOTULA 